Raffa Wealth Management’s Integra LifeSciences IART Stock Holding History

Raffa Wealth Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-26	Closed	-$1.42K	–	325
2017 Q2	$1.42K	Hold	26	–	–	﹤0.01%	321
2017 Q1	$1.09K	Buy	26 +10	+63%	+$427	﹤0.01%	318
2016 Q4	$686	Hold	16	–	–	﹤0.01%	591
2016 Q3	$660	Hold	16	–	–	﹤0.01%	590
2016 Q2	$638	Sell	16 -8	-33%	-$288	﹤0.01%	576
2016 Q1	$808	Hold	24	–	–	﹤0.01%	470
2015 Q4	$813	Hold	24	–	–	﹤0.01%	463
2015 Q3	$715	Sell	24 -5	-17%	-$156	﹤0.01%	502
2015 Q2	$808	Hold	29	–	–	﹤0.01%	454
2015 Q1	$740	Hold	29	–	–	﹤0.01%	498
2014 Q4	$651	Hold	29	–	–	﹤0.01%	533
2014 Q3	$596	Buy	+29	New	+$577	﹤0.01%	525
2014 Q1	–	Sell	-29	Closed	-$651	–	476
2013 Q4	$651	Buy	+29	New	+$532	﹤0.01%	533

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Raffa Wealth Management's IART Position: Q3 2017 in Review

Raffa Wealth Management sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 26 shares — an estimated $1.42K sold.

Raffa Wealth Management first reported a position in IART in Q4 2013 and held it in 13 quarters. The position peaked at $1.42K in Q2 2017. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

Raffa Wealth Management reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
Raffa Wealth Management sold 26 Integra LifeSciences shares in Q3 2017, an estimated $1.42K.
Raffa Wealth Management first reported a position in Integra LifeSciences in Q4 2013 and held it in 13 quarters.
Raffa Wealth Management's Integra LifeSciences position peaked at $1.42K in Q2 2017.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Raffa Wealth Management's 13F filing for Q3 2017, filed 27 Jul 2026.